IBB icon

iShares Biotechnology ETF

824 hedge funds and large institutions have $4.56B invested in iShares Biotechnology ETF in 2022 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 228 increasing their positions, 300 reducing their positions, and 73 closing their positions.

Holders
824
Holders Change
-29
Holders Change %
-3.4%
% of All Funds
14.25%
Holding in Top 10
14
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-6.67%
% of All Funds
0.24%
New
56
Increased
228
Reduced
300
Closed
73
Calls
$257M
Puts
$721M
Net Calls
-$464M
Net Calls Change
-$386M
Name Market Value Shares Shares
Change
Shares
Change %
BW
876
Bison Wealth
Georgia
-254 Closed
CPA
877
Cardiff Park Advisors
California
-249 Closed
Simplex Trading
878
Simplex Trading
Illinois
-205 Closed
FBC
879
Fairfield, Bush & Co
Connecticut
-159 Closed
BFG
880
Baron Financial Group
New Jersey
-156 Closed
SFG
881
Steward Financial Group
Texas
-135 Closed
GCM
882
Goldstream Capital Management
Hong Kong
-123 Closed
CWP
883
Concord Wealth Partners
Virginia
-109 Closed
SIAP
884
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
-90 Closed
COCM
885
Charter Oak Capital Management
New Hampshire
-64 Closed
AIP
886
Ahrens Investment Partners
Louisiana
-60 Closed
TFS
887
TrustCore Financial Services
Tennessee
$0 2 -60 -97%
LFASL
888
Lugano Financial Advisors SA (LFA)
Switzerland
-54 Closed
WOSD
889
WFA of San Diego
California
-30 Closed
GWMIA
890
Global Wealth Management Investment Advisory
Florida
-25 Closed
TCWM
891
Total Clarity Wealth Management
Illinois
-22 Closed
VRM
892
Vectors Research Management
New York
-19 Closed
RIM
893
Rockbridge Investment Management
New York
-14 Closed
HFS
894
Heritage Financial Services
Massachusetts
-11 Closed
RG
895
Retirement Group
California
-9 Closed
PAG
896
Paladin Advisory Group
Iowa
Walleye Trading
897
Walleye Trading
New York
PI
898
PEAK6 Investments
Illinois
CL
899
CSS LLC
Illinois
JGC
900
J. Goldman & Co
New York